PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.\', \'Harvard Medical School, Boston, MA 02115, USA.\', \'Department of Biomedical Sciences, Section of Pathology, Cummings School of Veterinary Medicine, Tufts University, North Grafton, MA 01536, USA.\', \'BIOQUAL Inc., Rockville, MD 20850, USA.\', \'Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.\', \'Janssen Vaccines & Prevention BV, Leiden, 2333 CN, Netherlands.\', \'Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA.\', \'Massachusetts Consortium on Pathogen Readiness, Boston, MA 02115, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1126/scitranslmed.abj3789
?:doi
?:hasPublicationType
?:journal
  • Science translational medicine
is ?:pmid of
?:pmid
?:pmid
  • 34705477
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 9.7
?:rankingScore_hIndex
  • 147
?:title
  • Immunity elicited by natural infection or Ad26.COV2.S vaccination protects hamsters against SARS-CoV-2 variants of concern.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34705477>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34705477>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all